Innovative Approaches to Hypertension Management in High-Risk Emergency Department Populations (aHTN-Manage)

April 13, 2026 updated by: Marcee Wilder, Icahn School of Medicine at Mount Sinai

Innovative Approaches to Hypertension Management in High-Risk Emergency Department Populations: A Feasibility Study

This single-center, single-arm quasi-experimental study will assess the feasibility and acceptability of a community health worker (CHW)-led intervention to address social determinants of health (SDOH) among emergency department patients with hypertension. At enrollment, participants (N=15) will complete standardized SDOH surveys in REDCap, and CHWs will facilitate referrals to local community-based organizations that address identified social needs. With participant consent, the study will also include medical record review through EPIC and Healthix to evaluate healthcare utilization-including emergency department visits, hospitalizations, and outpatient encounters-during the one-year period before and after the index ED visit.

Study Overview

Status

Recruiting

Study Type

Interventional

Enrollment (Estimated)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • New York
      • New York, New York, United States, 10029
        • Recruiting
        • Icahn School of Medicine at Mount Sinai
        • Principal Investigator:
          • Marcee Wilder, MD MPH

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 18 years and older who reside in the 5 boroughs of NYC,
  • whom speak English or Spanish,
  • have a known diagnosis of hypertension, and
  • have uncontrolled hypertension, defined as two measures of systolic blood pressure (SBP) ≥140 mmHg or diastolic blood pressure (DBP) ≥ 90 mmHg obtained during their ED visit.

Exclusion Criteria:

  • Patients who are unable to consent,
  • pregnant patients,
  • patients with a history of end stage renal disease, a history of heart failure or a BMI of greater than 50.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Participants with Hypertension
Participants with hypertension in high-risk Emergency Department populations
Engagement with Community Health Worker who will facilitate referrals to local community-based organizations

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants on study at 3 months
Time Frame: 3 months
Number of participants on study at 3 months to assess retention
3 months
Number of intervention engagement
Time Frame: 6 months
Number of interventions engagement based on number of types of CHW encounters
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acceptability of Intervention Measure (AIM)
Time Frame: baseline, 3 months, 6 months
AIM is a 4-item measure, each item scored on a 5-point Likert scale. Full scaled scored from 4 to 20, with higher score indicating greater acceptability, appropriateness and feasibility.
baseline, 3 months, 6 months
Intervention Appropriateness Measure (IAM)
Time Frame: baseline, 3 months, 6 months
IAM is a 4-item measure, each item scored on a 5-point Likert scale. Full scale scored from 4 to 20, with higher score indicating a greater level of appropriateness.
baseline, 3 months, 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Marcee Wilder, MD MPH, ISMMS

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Ahuja R, Ayala C, Tong X, Wall KH, Fang J. Public Awareness of Health-Related Risks From Uncontrolled Hypertension. Preventing Chronic Disease. 2018;15.
  • Akinyelure PO, Jaeger CB, Oparil S, et al. Social Determinants of Health and Uncontrolled Blood Pressure in a National Cohort of Black and White US Adults: the REGARDS Study. Hypertension. 2023;80(7):1403-1413.
  • Ware SK, Chidume T, Chou C. Social determinants of health and preventable emergency department patient encounters among adults with hypertension. Public Health Nursing. 2023;40(1):171-174.
  • Foster B, Dawood K, Pearson C, Manteuffel J, Levy P. Community Health Workers in the Emergency Department-Can they Help with Chronic Hypertension Care. Current Hypertension Reports. 2019;21(7).

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 12, 2026

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

July 31, 2026

Study Registration Dates

First Submitted

April 13, 2026

First Submitted That Met QC Criteria

April 13, 2026

First Posted (Actual)

April 20, 2026

Study Record Updates

Last Update Posted (Actual)

April 20, 2026

Last Update Submitted That Met QC Criteria

April 13, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • STUDY-25-00363
  • 1P50MD019475 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

IPD data is for research purposes only and will not be shared with any entity outside of those approved by PPHS.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Asymptomatic Hypertension

Clinical Trials on Community Health Worker engagement

Subscribe